Signup Crypto ETF Stocks News

What the Options Market Tells Us About MercadoLibre - MercadoLibre ( NASDAQ:MELI )

Investors with a lot of money to spend have taken a bearish stance on MercadoLibre MELI. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Source: www.benzinga.com
March 12, 2025 | 13:46:16
Category: News

Decoding Coca-Cola's Options Activity: What's the Big Picture? - Coca-Cola ( NYSE:KO )

Investors with a lot of money to spend have taken a bullish stance on Coca-Cola KO. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Source: www.benzinga.com
March 12, 2025 | 13:46:21
Category: News

The Lazy Lavender Introduces Signature "Stock Your Fridge" Service and Personalized Experiences, Redefining Vacation Rental Hospitality

WIMBERLEY, Texas, March 12, 2025 ( GLOBE NEWSWIRE ) -- The Lazy Lavender, the boutique vacation rental brand founded by Nathali and Cengiz, is revolutionizing the guest experience with its signature "stock your fridge" service and a suite of personalized offerings designed to make every stay ...

Source: www.benzinga.com
March 12, 2025 | 13:50:38
Category: News

Vereigen Media Redefines B2B Content Syndication with Verified Content Engagement

AUSTIN, Texas, March 12, 2025 ( GLOBE NEWSWIRE ) -- Businesses are actively adapting to tap into new methods and evolutions in how they market their products. Content syndication has served as the primary vehicle for demand generation for B2B marketers for decades, and as with all marketing, it ...

Source: www.benzinga.com
March 12, 2025 | 13:50:59
Category: News

Bitcoin, Ethereum, Dogecoin Rebound On Reserve Bill; Trump's 25% Metal Tariffs Begin, EU Strikes Back; February Inflation Slows More Than Expected - Top Headlines While The U.S. Slept

Bitwise Launches ETF Tracking Firms With Over 1,000 Bitcoin Melania Trump's Official Memecoin, Worth Over $13 Billion Barely Two Months Ago, Is Now Valued At $367 Million Dogecoin, XRP ETF Filings Delayed By SEC But Influential Analyst Says 'Relatively High' Odds Of Approval

Source: www.benzinga.com
March 12, 2025 | 13:53:26
Category: News

Israel-Based Cargo Shipping Company ZIM's Freight Boom: Q4 Sales Up 80% With 409% EBITDA Growth - ZIM Integrated Shipping ( NYSE:ZIM )

ZIM Q4 sales surged 80% Y/Y to $2.17B, driven by higher freight rates and 25% volume growth. Declared $3.17 per share dividend; expects 2025 EBITDA of $1.6B-$2.2B amid market volatility. Find out which stock just plummeted to the bottom of the new Benzinga Rankings.

Source: www.benzinga.com
March 12, 2025 | 13:54:21
Category: News

Big Screen Entertainment Group Enters the $500 Billion Beauty Industry - Big Screen Enter Gr ( OTC:BSEG )

LOS ANGELES, March 12, 2025 ( GLOBE NEWSWIRE ) -- Big Screen Entertainment Group BSEG is making a bold expansion into the booming beauty industry-an ever-growing global market projected to exceed $700 billion by 2028.

Source: www.benzinga.com
March 12, 2025 | 13:55:00
Category: News

Big Screen Entertainment Group Enters the $500 Billion Beauty Industry

Big Screen Enters the Beauty Business ...

Source: www.globenewswire.com
March 12, 2025 | 13:55:00
Category: News

Elon Musk Reportedly Pledges $100 Million to Trump-Linked Political Groups Amid Billion-Dollar Losses In His Net Worth - Tesla ( NASDAQ:TSLA )

Tesla TSLA and SpaceX CEO Elon Musk, who also serves as a consultant to the White House, has reportedly indicated plans to donate $100 million to organizations aligned with the Trump political network. What Happened: Three insiders have confirmed Musk's plans, as reported by the New York Times.

Source: www.benzinga.com
March 12, 2025 | 13:55:02
Category: News

Ionis Pharmaceuticals Partners With Japan-Based Ono Pharmaceutical For Rare Blood Disease Drug In Over $800 Million Deal - Ionis Pharmaceuticals ( NASDAQ:IONS )

Ionis will receive $280M upfront from Ono, with potential milestone payments of up to $660M and mid-teen percentage royalties on net sales. Sapablursen, an investigational RNA therapy for polycythemia vera, is in a fully enrolled Phase 2 trial.

Source: www.benzinga.com
March 12, 2025 | 13:56:23
Category: News

© Natavest 2025 - 2026